Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma
Clinical trial NCT04044378 · WITHDRAWN
Trial details
- NCT number
- NCT04044378
- Sponsor
- Peking University People's Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2021-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.